Repros Therapeutics Inc (NASDAQ:RPRX) - Share price - Overview

Stock Report

Repros Therapeutics Inc RPRX

Last Price
$0.46

Day Change
0.00|0.00%

As of 27/06/2017
16:44:16 EDT | USD
Minimum 15 Minutes Delay.

Last Close0.46
Day Range0.43 - 0.49
Mkt Cap-
52-Wk Range0.33 - 2.48
Yield %-
ISINUS76028H2094
Volume906,115
P/E-0.64
P/S312.50
P/CF-0.78

Share Price

Financials
201420152016
More ...
Income Statement
Revenue0.010.010.05
Operating Income-32.54-29.19-17.27
Net Income-32.54-29.19-17.27
Basic EPS-1.39-1.20-0.70
Avg. Diluted Shares Outstanding232425
Balance Sheet
Current Assets46.9121.488.75
Non Current Assets0.030.010.00
Total Assets46.9421.498.76
Current Liabilities2.922.922.66
Total Liabilities2.922.922.66
Total Equity44.0218.576.10
Cash Flow
Operating Cash Flow-29.33-25.33-15.58
Capital Expenditure---
Free Cash Flow---

In millions, except "Basic EPS". Currency is USD.

Company Profile

Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

21
Key Stats
More ...
Price/Earning TTM-0.64
Price/Book7.59
Price/Sales TTM306.67
Rev Growth (3 year avg)73.49
EPS Growth (3 year avg)-
Operating Margin % TTM-36,751.06
Net Margin % TTM-36,751.06
ROE TTM-140.06
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.